<DOC>
	<DOCNO>NCT01198938</DOCNO>
	<brief_summary>The investigator plan evaluate effect postoperative melatonin administration postoperative delirium patient undergo vascular cardiac surgery . A total 302 patient old 60 , undergo elective vascular surgery randomly divide 2 group : treatment control . During first 5 postoperative day patient receive sublingually either melatonin 5 mg placebo 9:00 pm . The patient assess sign delirium , quality sleep severity pain daily first postoperative week . Screening delirium perform specially train research assistant base Confusion Assessment Method validate chart review . Diagnosis delirium confirm psychiatrist . Incidence delirium compare group .</brief_summary>
	<brief_title>Postoperative Melatonin Administration Delirium Prevention Patients Undergoing Vascular Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Nonemergent vascular surgery , expect length stay ≥ 48hours , ASA categories I IV , sign informed consent , age &gt; 60 Lack informed consent , ASA category V , history psychiatric illness ( schizophrenia , psychosis , bipolar disorder , major depression ) , Mini Mental State Examination score ( MMSE ) ≤ 24 , history autoimmune disease , liver cirrhosis , minimally invasive procedure ( endovascular aneurysm repair ) , history chronic insomnia , chronic benzodiazepine and/or hypnotic use ( &gt; 3 time /week month prior surgery ) , treatment tricyclic antidepressant within month prior surgery , history seizure , allergy placebo ingredient melatonin ( WN Pharmaceuticals.LTD ) , melatonin consumption last month prior surgery .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Cardiac surgery , delirium , melatonin</keyword>
</DOC>